Bellevue Life Sciences Ac... (BLAC)
NASDAQ: BLAC
· Real-Time Price · USD
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM
Bellevue Life Sciences Acquisition Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.3 | -6.39 | -47.63 | -112.04 | -248.44 | -225.76 | 301.13 | 77.04 | 207.28 | -1.6K | -1K | -20.27K | -158.91K | -61.87K | -168.26K | -7.26K | -160.66K |
PEG Ratio | -0.00 | -0.01 | -0.35 | -0.89 | 32.02 | 1.05 | -4.52 | 0.53 | -0.24 | 44.56 | -0.42 | -38.28 | 2.6K | -359.79 | 1.77K | -4.02 | n/a |
PS Ratio | 17.72 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | n/a | -7.97 | 2.95 | 2.88 | 1.85 | 2.39 | 1.37 | 1.35 | 1.33 | -2.44K | -3.44K | -24.77K | n/a | -37.59K | n/a | n/a | n/a |
P/FCF Ratio | n/a | -102.76 | -193.97 | -30.78 | -1.44K | -278.42 | -657.51 | -267.26 | -1.89K | -96.07K | 21.13K | -11.53K | -635.66K | -658.59K | 15.48K | n/a | n/a |
P/OCF Ratio | n/a | -102.76 | -193.96 | -30.78 | -1.44K | -278.42 | -657.51 | -267.26 | -1.89K | -96.07K | 21.13K | -11.53K | -635.66K | -658.59K | 15.48K | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | -0.27 | 0.12 | 0.10 | 0.00 | n/a | 0.00 | n/a | n/a | -31.99 | -38.7 | -278.29 | n/a | -188.68 | n/a | n/a | n/a |
Quick Ratio | n/a | 0.07 | 0.01 | 0.05 | 0.02 | 0.01 | 0.07 | 0.11 | 1.07 | 0.10 | 0.06 | 0.07 | n/a | 0.01 | n/a | n/a | n/a |
Current Ratio | n/a | 0.07 | 0.01 | 0.05 | 0.02 | 0.01 | 0.07 | 0.11 | 1.07 | 0.10 | 0.06 | 0.07 | n/a | 0.01 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | 177.94 | 49.85 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | n/a | 0.31 | -0.02 | -0.01 | n/a | n/a | n/a | n/a | n/a | 0.38 | 0.86 | 0.31 | n/a | 0.15 | n/a | n/a | n/a |
Return on Assets | n/a | -0.88 | -0.01 | n/a | n/a | n/a | n/a | n/a | n/a | -0.01 | -0.02 | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Invested Capital | n/a | 0.59 | -0.03 | -0.25 | 0.03 | 0.03 | n/a | n/a | n/a | -0.01 | -0.02 | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -14.97 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -14.97 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -3.83 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -3.83 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |